Role of Pramipexole in Delaying L-dopa Induced Dyskinesia and Enhancing the Response to L-dopa in 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian Mice
L-dopa remains the most effective treatment for Parkinson‟s disease (PD). However, its effectiveness declines on continuous use, leads to motor complications, and does not modify the progression of the neurodegenerative process. Medical therapy that provides the benefits of l-dopa without motor comp...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KenzPub
2012-06-01
|
| Series: | Egyptian Journal of Basic and Clinical Pharmacology |
| Online Access: | http://www.kenzpub.com/journals/ejbcp/2012/101332/ |